Chemotherapy Induced Emesis – Mechanisms and Treatment: A Review

Borison H.L. , Wang S.C. . Physiology and pharmacology of vomiting. Pharmacol Rev 1953; 5: 192–230

Brizzee K.R. , Clara P.M. . The structure of the mammalian area postrema. Fed Proc 1984; 43: 2944–8

Davis C.J. , Harding R.K. , Leslie R.A. , Andrews P.L.R. . The organisation of vomiting as a protective reflex: In: Davis C.J. , ed. Nausea and vomiting: mechanisms and treatment. Heidelberg: Springer-Verlag, 1984: 65–77

Carpenter D.O. , Briggs D.B. , Strominger N. . Behavioural and electrophysiological studies of peptide-induced emesis in dogs. Fed Proc 1984; 43: 2952–4

Leslie R.A. , Gwyn D.G. . Neuronal connections of the area postrema. Fed Proc 1984; 43: 2941–3

Pickel V.M. , Armstrong D.M. . Ultrastructural localizations of monoamines and peptides in rat area postrema. Fed Proc 1984; 43: 2949–51

Borison H.L. , Borison R. , McCarthy L.E. . Role of the area postrema in vomiting and related functions. Fed Proc 1984; 43: 2955–8

Borison H.L. , Wang S.C. . Functional localization of central coordinating mechanism for emesis in cats. J Neurophysiol 1949; 12: 305–13

Miller A.D. , Wilson V.J. . ‘Vomiting Center’ reanalysed: an electrical stimulation study. Brain Res 1983; 270: 154–8

Harris A.L. . Cytotoxic-therapy induced vomiting is mediated via enkephalin pathways. Lancet 1982; i: 714–16

Willems J.L. , Lefebvre R.A. . Peripheral nervous pathways involved in nausea and vomiting. In: Davis C.J. , ed. Nausea and vomiting: mechanisms and treatment Heidelberg: Springer-Verlag, 1984: 56–64

McCarthy L.B. , Borison H.L. . Cisplatin-induced vomiting eliminated by ablation of the area postrema in cats. Cancer Treat Rep 1984; 68: 401–4

Borison H.C. , McCarthy L.E. . Neuropharmacologic mechanisms of emesis. In: Laszlo J. , ed. Antiemetics and cancer chemotherapy. Baltimore: Williams & Wilkins, 1983: 6–29

Bhargava K.P. , Dixit K.S. , Gupta Y.K. . Enkephalin receptors in the emetic chemoreceptor trigger zone of the dog. Br J Pharmacol 1981; 72: 47P–47S.

Costello D.J. , Borison H.L. . Naloxone antagonizes narcotic self-blockade of emesis in the cat. J Pharmacol Exp Ther 1977; 203: 222–30

Moher D. , Arthur A.Z. , Pater J.L. . Anticipatory nausea and/or vomiting. Cancer Treat Rev 1984; 11: 257–64

Bakowski M.T. . Advances in anti-emetic therapy. Cancer Treat Rev 1984; 11: 237–56

Rawlins M.D. , Taylor W.B. , Bateman D.N. . Rational approaches to therapy for nausea and vomiting: two common solutions. In: Davis C.J. ed. Nausea and vomiting: mechanisms and treatment. Heidelberg: Springer-Verlag. 1984: 167–71

Huys J. . Cytostatic-associated vomiting effectively inhibited by domperidone. Cancer Chemother Pharmacol 1978; 1: 215–18

Harris A.L. , Cantwell B.M.J. . Mechanisms and treatment of cytotoxic-induced nausea and vomiting. In: Davis CJ , ed. Nausea and vomiting: mechanisms and treatment. Heidelberg: Springer-Verlag. 1984: 78–93

Drapkin R. , McAloon E. , Sokol G. . The antiemetic effect of dexamethasone in patients receiving cisplatin. Proc ASCO 1981; 22: 419

Miner W.D. , Sanger G.J. . Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine m-receptor antagonism. Br J Pharmacol 1986; 8: 497–9

Carmichael J. , Cantwell B.M.J. , Edwards C. , Rapeport G. , Harris A.L. . The serotonin type 3 receptor antagonist BRL 43694 and nausea and vomiting induced by cisplatin. Br Med J [Clin Res] 1988; 297: 110–1

Dundee J.W. , Ghaly R.G. , Fitzpatrick K.T.J. . Optimising antiemesis in cancer chemotherapy. Br Med J [Clin Res] 987; 294: 179

Robertson G.L. . The regulation of vasopressin function in health and disease. Recent Prog Hormone Res 1977; 33: 333–85

Forrest G.J. , Wallace D. , Cunningham D. β-Endorphine – a modulator of emesis in patients receiving chemotherapy? 1987. Proc BACR.